Search results
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 57 minutes agoModerna has announced that its Phase III clinical trial of the investigational next-generation Covid...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 15 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 4 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 22 hours agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 13 hours agoThey have tips on what you need to know this season. (Getty Images) Vera Vita via Getty Images It’s...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 2 days agoAt this time, mRNA-1083 is poised to be the first Covid-19/influenza combination vaccine and the...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC NEWS· 12 hours agoThe Food and Drug Administration said Thursday it had advised drugmakers to update the Covid ...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 17 hours agoKP.3 accounts for 25% of cases, while another variant, KP.2, makes up about 22% of cases. Experts...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
CNN.com· 4 days agoThere could be a combined Covid-19 and flu shot in our future, although it won’t be ready for this...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via AOL· 11 hours agoNextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines and therapeutics ...